Novartis

Interested in learning more about
expert clinical insights into

AML & ADVANCED SM?

The promotional event is for HCPs licensed to practice medicine in the E.U. only.

AML, acute myeloid leukaemia; SM, systemic mastocytosis.

Join renowned experts for a

VIRTUAL PANEL AND Q&A

to further explore these diseases & treatment with targeted therapy

Prof. Richard Schlenk
Head of Clinical Trials Center
National Center for Tumor Diseases
Heidelberg, Germany

Dr. Deepti Radia
Guy's and St. Thomas's NHS Foundation Trust
London, UK

LEARN MORE ABOUT
AML & ADVANCED SM

REGISTER NOW